Komori
Bml (4694) · InitiativeSoftened

Preparation for the launch of the cloud-based electronic medical record system

First written in FY2020-Q1. 4 of 14 entries say "Advanced", first in FY2020-Q2. Latest entry: FY2025-H1.

14entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2020-Q3 – FY2021-Q2SoftenedFY2023-Q3 – FY2024-Q22019: 220192020: 220202021: 120212022: 420222023: 220232024: 32024
Same theme, other companies
Transition of Medical Systems to Cloud SaaSA theme 9 companies write about · 1 as a headwind · 11 as a tailwind

The whole theme swung hardest in 2026: 1 of 6 companies on the "Worse" side.

0 other companies' latest entry also says "Softened".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2025-H1SoftenedAnnual report

    「In the medical information systems business, revenue decreased 1.0% year on year as new sales remained sluggish following the temporary suspension of Qualis Cloud sales, while implementations declined as demand for online eligibility verification and related systems reached a peak.」

    Qualis Cloud remains in a state of temporary sales suspension. No timing for resuming sales was indicated, and a decline in revenue due to sluggish new sales was reported.
  2. FY2024SoftenedAnnual report

    「The company is preparing to resume sales of the cloud-based electronic medical records.」

    The previously indicated specific timing for resuming sales was no longer stated, and the description changed to continuing preparations.
  3. FY2024-Q3AdvancedAnnual report

    「Cloud-based electronic medical records are scheduled to resume sales around August 2024.」

    For the cloud-based electronic medical records system, whose sales were temporarily suspended, the company indicated the specific timing of around August 2024 for resuming sales.
  4. FY2024-Q2SoftenedAnnual report

    「Sales of the cloud-based electronic medical records system were temporarily suspended after we determined that additional resources were needed to maintain service levels in response to the rapid increase in the number of facilities adopting the system.」

    Sales of the cloud-based electronic medical records system were temporarily suspended to increase resources for service maintenance in response to the rapid increase in the number of adopting facilities.
  5. FY2023-Q3SoftenedAnnual report

    「Revenue from the medical information systems business increased 8.5% year on year, reflecting sales of the cloud-based electronic medical records system released in April 2022 progressing broadly as planned and strong orders for online eligibility verification.」

    The description of sales of the cloud-based electronic medical records system changed from “as planned” to “broadly as planned.”
  6. FY2023-Q2RestatedAnnual report

    「Revenue from the medical information systems business increased as sales of the cloud-based electronic medical records system released in April 2022 progressed as planned, while maintenance revenue remained firm.」

    Following the April 2022 release of the cloud-based electronic medical records system, sales progressed as planned and maintenance revenue remained firm.
  7. FY2023-Q1AdvancedAnnual report

    「Revenue in the medical information systems business increased 14.4% year on year, as sales of the cloud-based electronic medical records system released in April 2022 progressed as planned and maintenance revenue remained steady.」

    Following the release of the cloud-based electronic medical records system, sales progressed as planned and maintenance revenue remained firm.
  8. FY2022AchievedAnnual report

    「In April 2022, we released a new cloud-based electronic medical records system.」

    The planned April 2022 release of the cloud-based electronic medical records system was subsequently recorded as an actual release.
  9. FY2022-Q3RestatedAnnual report

    「The cloud-based electronic medical records system is scheduled for release in April 2022.」

    The company has reconfirmed that the cloud-based electronic medical records system is scheduled for release in April 2022.
  10. FY2022-Q1AdvancedAnnual report

    「The cloud-based electronic medical records system is scheduled for release in April 2022.」

    For the cloud-based electronic medical records system, the company progressed from its previous development and preparations toward commercial launch to specifying April 2022 as the planned release date.
  11. FY2021-Q2RestatedAnnual report

    「We are continuing development of the cloud-based electronic medical records system so that it can be commercially launched.」

    Development of the cloud-based electronic medical records system is continuing toward commercial launch.
  12. FY2020-Q3RestatedAnnual report

    「In addition, we are preparing the cloud-based electronic medical records system for commercial launch.」

    The company continues to prepare the cloud-based electronic medical records system for commercial launch.
  13. FY2020-Q2AdvancedAnnual report

    「We are also preparing for pilot operations of the cloud-based electronic medical records system ahead of commercial launch.」

    For the cloud-based electronic medical records system, the company has moved from indicating a planned start date for pilot operations to preparing for operations.
  14. FY2020-Q1First statedAnnual report

    「We plan to begin pilot operations of a cloud-based electronic medical records system this autumn in preparation for its launch.」

    For the cloud-based electronic medical records system, the company has, for the first time, indicated plans to begin pilot operations this autumn ahead of commercial launch.
Moved together

"Growth of the electronic medical records and medical information systems businesses" moved the same way as this thread, in the same document, in 5 of its 14 moves.

544333★123456
  1. ★This thread
  2. 1Growth of the electronic medical records and medical information systems businesses5×
  3. 2Maintaining stable dividends and increasing dividend levels4×
  4. 3Decline in dispensing pharmacy revenue due to lower drug prices4×
  5. 4Accelerating growth in the food safety business3×
  6. 5Strengthening food safety consulting and testing systems3×
  7. 6Returning capital and improving capital efficiency through share repurchases and tender offers3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Bml's next results are scheduled for 2026-11-11. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.